PERIPHERAL VASCULAR CONTROL MECHANISMS
外周血管控制机制
基本信息
- 批准号:2217448
- 负责人:
- 金额:$ 19.92万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1985
- 资助国家:美国
- 起止时间:1985-04-01 至 1997-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Leukotrienes (LT) C4 and D4 are the principal Components of slow reacting
substance of anaphylaxis (SRS-A). Results of previous studies have shown
that these substances have the capacity to produce endothelium dependent
vasomotor relaxation, which, in arteries, is dependent on the release of
an endothelium derived relaxing factor (EDRF). The factor released by
LTD4 from arteries could not be distinguished by pharmacological criteria
from the classical EDRF, considered to be nitric oxide (NO) or an
unstable nitroso compound that releases NO. In contrast to these
observations, it was found that LTD4 induced endothelium-dependent
relaxation of the renal vein in a more potent and efficacious manner, but
the vasorelaxant activity was due to a mechanism or mediator other than
cyclooxygenase-derived products of arachidonic acid, the classic EDRF/NO,
or vascular smooth muscle hyperpolarization consequent to ATP-sensitive
K+ channel activation. More recent observations suggest that multiple
signal transduction pathways and perhaps different LT receptors may
account for the diverse activity of these substances in arteries and
veins. Additionally, both LTC4 and LTD4 evoke marked endothelium-
dependent relaxation of visceral capacitance veins. These latter
observations appear to be consistent with the known hemodynamic changes
which occur during anaphylactic shock, including hypotension and a fall
in cardiac output associated with a reduction in venous return to the
heart secondary to vasodilation of splanchnic venous capacitance
vasculature. It was these aforementioned observations that led to the
formulated working hypotheses: a) endothelium dependent relaxation evoked
in veins by LTs is consequent to a mechanism/mediator that differs from
EDRF/NO and b) receptors for LTs localized on venous and arterial
endothelium differ. In order to evaluate these hypotheses, studies are
proposed to: comprehensively characterize evoked changes in vasomotor
tone in isolated vascular ring preparations; identify and characterize,
via bioassay, vasomotor mediators derived from vascular segments or
primary endothelial cell cultures; and define receptor binding
characteristics of LTs on endothelial cell membranes. Overall knowledge
gained from these studies will help to improve our understanding of the
role of these potent endogenous substances in the regulation of vasomotor
tone and peripheral hemodynamics.
白三烯(LT) C4和D4是慢反应的主要成分
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
BARRY M CHAPNICK其他文献
BARRY M CHAPNICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('BARRY M CHAPNICK', 18)}}的其他基金
相似国自然基金
ITS-HPLC-HRMS-Bioassay多级筛选策略指导下海洋真菌中新型抗菌活性产物的发现
- 批准号:41606166
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Development of advanced bioassay analysis system for internal dose assessment
开发用于内部剂量评估的先进生物测定分析系统
- 批准号:
23H03142 - 财政年份:2023
- 资助金额:
$ 19.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
This service is for The BPN Biologics program requires bioassay development expertise in order to support active cooperative agreements for drug development and discovery.
该服务适用于 BPN Biologics 计划需要生物测定开发专业知识,以支持药物开发和发现的积极合作协议。
- 批准号:
10949343 - 财政年份:2023
- 资助金额:
$ 19.92万 - 项目类别:
Development of a three-dimensional microkidney model and its disease model for bioassay
用于生物测定的三维微肾脏模型及其疾病模型的开发
- 批准号:
23H01983 - 财政年份:2023
- 资助金额:
$ 19.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of a qualified pharmacokinetic bioassay to support preclinical and clinical studies of MM-008, a non-hormonal contraceptive antibody
开发合格的药代动力学生物测定法以支持非激素避孕抗体 MM-008 的临床前和临床研究
- 批准号:
10459074 - 财政年份:2022
- 资助金额:
$ 19.92万 - 项目类别:
Development of rapid and sensitive bioassay methods to contribute to actinide internal exposure medical response
开发快速、灵敏的生物测定方法,有助于锕系元素内照射医疗反应
- 批准号:
22K12384 - 财政年份:2022
- 资助金额:
$ 19.92万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of simple bioassay for detection of environmental trace contaminants and demonstration in Asian countries
开发用于检测环境痕量污染物的简单生物测定法并在亚洲国家进行示范
- 批准号:
21H01577 - 财政年份:2021
- 资助金额:
$ 19.92万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
L2M Market Assessment Grant: a bioassay to predict birth timing.
L2M 市场评估补助金:预测出生时间的生物测定。
- 批准号:
571251-2022 - 财政年份:2021
- 资助金额:
$ 19.92万 - 项目类别:
Idea to Innovation